Patent · US Active

Quinoline derivatives as anti-cancer agents

US9493419B2 · kind B2 · utility

9Cited by

5References

22Claims

0Family size

Assignee

The Hong Kong Polytechnic University · CN

Inventors

Johnny Cheuk-on Tang · Hong Kong, CN
Albert Sun-Chi Chan · Kowloon, CN
Kim-hung Lam · Hong Kong, CN
Sau Hing Chan · Hong Kong, CN

Key dates

Filing date	Dec 22, 2011
Grant date	Nov 15, 2016
Priority date	—
Expiry date	Dec 22, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D215/227
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Quinoline derivatives showing anticancer activities against cancer cell lines of hepatocellular carcinoma (Hep3B), lung carcinoma (A549), esophageal squamous cell carcinoma (HKESC-1, HKESC-4 and KYSE150). The quinoline derivatives have a backbone structure of the following formulas:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.